Candida antarctica Lipase Resolution of N-Protected Beta-Lactams

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for stereoselective methods to synthesize or enrich stereoisomers of pharmaceuticals and intermediates, particularly for chiral compounds like β-lactams and β-amino carboxylic acids, as existing methods often result in low yields and poor enantiomeric excess, and current biocatalytic processes are inefficient for producing stereoisomerically pure products.

Innovation Solution

The method involves contacting a racemic mixture of N-protected β-lactams with a lipase from Candida antarctica, which selectively hydrolyzes one enantiomer while leaving the other intact, using a carbamate protecting group to enhance reactivity and stability, allowing for the production of stereoisomerically pure β-lactam and β-amino carboxylic acid derivatives in high yields.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthetic chemistry is used to separate or resolve chiral molecules, then stereoisomers can be obtained, but the process requires multiple protecting group manipulations and additional steps

Engineering Contradiction:
Improvestereoisomeric purityVSAvoidnumber of synthetic steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces conventional chemical synthetic methods with enzymatic biocatalysis. The lipase enzyme from Candida antarctica selectively hydrolyzes one enantiomer of the racemic N-protected β-lactam, directly producing stereoisomerically pure products without requiring protecting group manipulations or multiple synthetic steps.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The enzyme performs the stereoselective resolution automatically through its inherent chiral recognition capability. The lipase naturally distinguishes between enantiomers and catalyzes the hydrolysis of the desired stereoisomer, eliminating the need for complex external intervention or additional purification steps.

Inventive Principle:
Principle #25Self-service

2Manufacturing precision

If conventional biocatalytic processes are used for resolving racemic mixtures, then stereoisomers can be enriched, but the yields are low and enantiomeric excess is poor

Engineering Contradiction:
Improveenantiomeric excessVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent optimizes reaction parameters including using N-protecting groups (carbamates, carbonyl diimines, or thiocarbamates) that enhance both reactivity and stability. The reaction is conducted in organic solvents with controlled water content, and temperature is optimized to achieve both high enantiomeric excess (>90% ee) and high yield (>50%) simultaneously.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The N-protecting group acts as an intermediary that facilitates the enzymatic reaction. These protecting groups enhance the substrate's reactivity toward the lipase while maintaining stability, enabling the enzyme to achieve high stereoselectivity and high conversion efficiency without compromising the β-lactam ring integrity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If stereoselective synthesis methods are developed, then enantiomerically pure pharmaceuticals can be produced, but the current methods are inefficient for producing stereoisomerically pure products

Engineering Contradiction:
Improvestereoisomeric purityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The lipase from Candida antarctica serves multiple functions: it acts as a stereoselective catalyst for resolving racemic mixtures, works with various N-protected β-lactam substrates, and operates efficiently in organic solvent systems. This universal enzyme can handle different substrates and protecting groups while maintaining high stereoselectivity and productivity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The methodology employs optimized reaction conditions including specific N-protecting groups (carbamates, carbonyl diimines, thiocarbamates), organic solvents with controlled water content (0.1-5%), and temperature optimization (20-40°C). These parameter changes enable simultaneous achievement of high enantiomeric excess (>90% ee) and high yield (>50%), making the process both precise and productive.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the efficient production of stereoisomerically pure β-lactam and β-amino carboxylic acid derivatives, which can be used as starting materials for synthesizing specific diastereomers, achieving high yields and enantiomeric purity, thereby addressing the limitations of existing methods.

Implementation Method 1

contacting a (2-exo, 3-exo) cis β-lactam comprising a mixture of enantiomers with a lipase from Candida antarctica to yield stereoisomerically pure products

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

selectively hydrolyzes one enantiomer while leaving the other intact

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS7459301B2Stereoisomerically enriched N-protected beta-lactams using candida antarctica
Publication Date: 2008.12.02 RIGEL PHARMACEUTICALS INC
  • US7459301B2 patent drawing
  • US7459301B2 patent drawing
  • US7459301B2 patent drawing

AI summary

The present disclosure provides enzymatic methods for generating stereoisomerically pure products by resolving a racemic mixture of N-protected β-lactams with a lipase from Candida antarctica with high stereospecificity. The presence of a carbamate protecting group, such as the tert-butoxycarbonyl group protecting group, on the β-lactam enhances enzyme catalysis and stereoselectivity.